294
Participants
Start Date
January 31, 2008
Primary Completion Date
February 28, 2014
Study Completion Date
February 28, 2014
Pegasys plus Entecavir
Pegasys 180 mcg in 0.5 mL solution administered sc once weekly for 24 weeks plus entecavir (0.5mg mg/capsule) 0.5 mg administered po daily for 24 weeks
Entecavir
ETV 0.5 mg daily monotherapy for 144 weeks
RECRUITING
National Taiwan University Hospital Department of Internal medicine, Taipei
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
National Taiwan University Hospital
OTHER